2024 State of Science: An Update on Consumer Sentiments in Life Science
cori sherman cori sherman

2024 State of Science: An Update on Consumer Sentiments in Life Science

In our latest update on the LINUS State of Science study, we continue to track the priorities, productivity expectations, and economic outlooks of scientists around the world. We’re seeing the second half of 2024 bring increased interest in AI and multi-omics, with scientists looking to trusted sources of information for guidance and support.

Read More
Understanding biopharma's AI integration strategy: What's the plan?
cori sherman cori sherman

Understanding biopharma's AI integration strategy: What's the plan?

We heard resoundingly from our pharma partners that they’re looking to AI and automation to meet productivity demands this year. But, what does adoption of AI tools really look like for this audience? We engaged with 25 pharma leaders to better understand their goals, challenges, and operational needs. Here’s a summary of what we learned.

Read More